QuantLogix ← AMCR scorecard
📅 AMCR Earnings Preview
AMCR
Next report (est.)
11/13/2026
Countdown
17 days
EPS growth YoY
+0.0%
Revenue growth YoY
+25.9%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/14/2026 ±2.8% -0.8% over-priced
05/07/2026 ±4.0% -0.7% over-priced
02/04/2026 ±2.5% +8.1% under-priced
11/06/2025 ±2.6% +1.9% over-priced
08/15/2025 ±4.7% -0.3% over-priced
05/01/2025 ±3.1% -1.3% over-priced
02/05/2025 ±2.4% +1.7% over-priced
11/01/2024 ±1.4% -7.8% under-priced
Across these reports, options implied an average ±3.0% move vs an actual average of 2.8% — the stock stayed inside the implied band 75% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q4 FY2026 — $6.4B $389M
Q3 FY2026 $0.60 $5.9B $278M
Q2 FY2026 $0.38 $5.4B $177M
Q1 FY2026 $0.11 $5.7B $262M
Analyst posture
Buy / Strong Buy
13
Hold
7
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 68/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on AMCR before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

AMCR (AMCR) reports in 17 days, with the next report estimated for 11/13/2026. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 2.8% on average — the market has systematically over-priced AMCR's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 25.9%. QuantLogix's live 5-factor engine currently reads AMCR as a buy at 68/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →